Skip to content

Day 135: If AI Can Answer the Question, What Is Left to Buy?

A CMO asks an answer engine how to improve the company's visibility in AI-led research.

The answer is good. It explains that the company needs clear public information about its offer, accurate category language, useful evidence, accessible pages, and buyer questions worth investigating. It warns against treating one captured answer as market truth. It suggests looking at competitors, sources, and the routes a buyer may be offered.

Ten minutes later, the CMO understands the subject better. She still cannot responsibly decide what her company should change first.

She does not know whether the problem sits in positioning, product information, third-party evidence, technical access, or the questions being measured. She cannot tell which gap affects a live commercial priority. Nobody owns implementation.

That gap is where a credible paid offer begins.

As general explanations become easier to obtain, charging for access to the explanation becomes harder to defend. The commercial value has to survive the summary. It should sit in the diagnosis made under the buyer's conditions, the priority chosen among real trade-offs, the evidence created or verified, the change delivered, and the responsibility carried when the decision has consequences.

A useful answer is not the same as a company decision

The scenario is generalised, not a reported client result or a claim about how every answer engine behaves.

Suppose the CMO leads a B2B company with three active offers, an inherited website, a small marketing team, and a major launch approaching. Public descriptions of the company vary. One offer has strong technical documentation but little independent evidence. Another has credible customer stories but unclear current scope. The third is commercially important and barely explained outside sales conversations.

A strong public answer can teach her what to inspect. It may help her ask better questions. It cannot examine private sales context, settle contested product language, confirm which evidence the company is permitted to publish, or choose which offer deserves scarce implementation capacity.

Those decisions require company-specific work:

  • establish what important buyers are trying to decide;
  • inspect what public material currently supports or confuses that decision;
  • separate a visible symptom from the underlying commercial problem;
  • choose which intervention deserves budget now and which should wait;
  • create or verify missing evidence without inventing certainty;
  • make the approved changes across the relevant teams and surfaces;
  • accept responsibility for the recommendation, its limits, and the next review.

The CMO is not buying a longer explanation of GEO. She is buying a defensible route from an ambiguous market problem to an implemented business change.

If the summary destroys the offer, the offer was too thin

This creates an uncomfortable test for advisory firms, agencies, platforms, and internal teams.

Imagine an answer engine can produce a competent summary of the public method: define commercially important questions, inspect answer-led and search-led surfaces separately, record the conditions, audit the public material, compare relevant alternatives, and avoid claiming that a mention caused revenue.

What paid value remains?

If the honest answer is "a more detailed version of the same checklist", the offer is vulnerable. Its scarcity depended on information being difficult to find. Better summaries remove some of that friction.

A stronger offer has value that cannot be copied out of a general answer because the work changes with the buyer's situation. Which questions matter depends on the offer, market, sales motion, current evidence, operational capacity, and risk. The right priority may be a positioning decision, a missing proof asset, a technical repair, a product clarification, a sales route, or no intervention yet. The recommendation becomes valuable because it excludes plausible but weaker actions and commits the organisation to a supported choice.

Implementation matters for the same reason. A recommendation that nobody can approve, resource, publish, measure, or defend is not a commercial transformation. Paid work should specify who will move the change through the business, what evidence must exist, where uncertainty remains, and what risk the provider is prepared to own.

Publish enough to make the buyer more capable

The response should not be to make public material deliberately unhelpful.

A company can explain the problem clearly, publish useful evaluation criteria, describe what a sensible first review involves, and state the limits of the available evidence. A buyer should be able to learn something material without surrendering contact details or sitting through a disguised sales pitch.

Useful public knowledge can also make the company and its expertise easier for people, search systems, and answer-led systems to interpret under some recorded conditions. That is a possibility, not a promise of inclusion, ranking, citation, recommendation, traffic, attribution, conversion, or revenue.

Publishing the basics does more than support discovery. It improves the buying conversation. The prospect arrives able to challenge weak assumptions. They can distinguish a quick visibility check from diagnosis, a content suggestion from an approved commercial priority, and an interesting observation from evidence strong enough to fund action.

That may reduce the number of conversations built on avoidable confusion. Good. A paid engagement should not need confusion to survive.

Make the paid change explicit

The offer page, proposal, and first conversation should name what the buyer pays to change.

For the generalised CMO, the engagement might be responsible for producing a prioritised diagnosis across one named offer and market, obtaining the evidence needed to support the chosen intervention, moving approved changes into the public buying surface, and giving leadership an accountable recommendation with clear limits.

That is more concrete than "AI visibility consulting" and more defensible than selling access to information. It lets the buyer ask hard questions:

  • Which company-specific uncertainty will be resolved?
  • What decision will the work make safer or easier?
  • Which evidence must be created, verified, or rejected?
  • Who owns implementation when the finding crosses marketing, product, sales, or technical work?
  • Which risk remains with us, and which responsibility does the provider accept?
  • What will exist or operate differently when the engagement ends?

The answers may point to a bounded diagnosis, implementation work, an evidence programme, or an ongoing operating service. They may also show that the buyer only needs the public guidance. That is a valid outcome. Commercial confidence includes knowing when not to inflate an informational need into a larger engagement.

Do not price this around hours supposedly saved. The stronger basis is the commercial consequence of making the wrong choice, delaying a necessary one, creating unsupported claims, sending the wrong work into delivery, or leaving a material buyer problem unresolved.

Use a compact public-versus-paid test

Before gating a piece of knowledge or packaging an engagement, apply four questions.

  1. Can a responsible reader use this safely without company-specific access? Publish the explanation, criteria, caveats, and self-check when the answer is yes.
  2. Does the answer depend on private conditions, contested priorities, or evidence that must be examined? That is diagnosis, not hidden information.
  3. Will value require coordinated change rather than understanding alone? Name the implementation, approvals, evidence work, and organisational burden in the paid scope.
  4. Who is accountable if the recommendation is wrong or the change stalls? Make ownership and managed risk part of the offer instead of leaving them with the buyer by default.

This is a boundary test, not a rule that every public explanation must become exhaustive. Confidential data, protected methods, security details, and unverified material should remain controlled. The point is narrower: do not hide buyer-useful basics merely because the commercial offer has not yet explained its value beyond them.

Keep the platform promise modest

Google's official guidance says the usual Search fundamentals remain relevant for AI Overviews and AI Mode. It says there are no additional technical requirements and no need for new machine-readable files, AI text files, special markup, or special schema.org structured data to appear in those features.[1]

That rules out an easy but weak commercial answer: selling llms.txt, special AI markup, arbitrary content chunking, or over-focused structured data as required Google AI visibility switches.

Accurate, useful public explanations may support understanding and discovery. They still cannot control what a system includes, cites, ranks, recommends, or sends to the business. The paid value should therefore not depend on a deterministic platform promise. It should depend on work the provider can inspect and own: the quality of the diagnosis, the priority chosen, the evidence standard, the implementation, and the commercial decision made possible.

Ask what remains after the answer

Put one offer through the summary test.

Assume a capable buyer can get a clear explanation of the subject before speaking to you. Remove "access to knowledge" from the value proposition. Then ask what remains worth buying.

If the answer is specific judgement under real conditions, a defensible priority, missing evidence, implemented change, organisational movement, and accountable risk, say that plainly. Show the buyer what will be different because the engagement happened.

If little remains beyond a better-packaged explanation, do not make the explanation harder to find.

Make the offer stronger.

Sources

[1] https://developers.google.com/search/docs/appearance/ai-features — Google Search Central: AI features and your website